[1]
L. Endrenyi and L. Tothfalusi, “Regulatory and Study Conditions for the Determination of Bioequivalence of Highly Variable Drugs”, J Pharm Pharm Sci, vol. 12, no. 1, pp. 138–149, May 2009.